ANN PEREIRA: Open Payments
NPI 1285144758 · AURORA, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$806 in 39 payments from 15 companies in 2025. Trend: 2023 $1,510 · 2024 $1,235 · 2025 $806
Food & beverage: $806
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 6 | $100 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $99 |
| Amgen Inc. | 4 | $84 |
| E.R. Squibb & Sons, L.L.C. | 3 | $80 |
| BridgeBio Pharma, Inc. | 3 | $75 |
| Edwards Lifesciences Corporation | 2 | $62 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $62 |
| AstraZeneca Pharmaceuticals LP | 3 | $50 |
| Novartis Pharmaceuticals Corporation | 2 | $40 |
| Alnylam Pharmaceuticals Inc. | 1 | $31 |
Products named: Kerendia, REPATHA, ELIQUIS, Attruby, JARDIANCE, CAMZYOS, VYNDAQEL, LEQVIO.
Industry payments across CO — which companies pay providers there.
